Click on an event to access its materials, such as videos, transcripts, and presentations.
Dr. Stephen Hahn addressed the role of the U.S. Food and Drug Administration in the COVID-19 response and best practices and lessons learned from the emergency response to date.
This briefing explored how our supply chain must respond to manufacture millions of doses and then swiftly deliver them to administration sites. Panelists also illustrated the steps these stakeholders might take in the first 48 hours after an Emergency Use Authorization is approved.
This discussion focused on measures industry stakeholders have taken for safe COVID-19 vaccine deployment and the immediate steps these stakeholders will take in the first 48 hours after the Emergency Use Authorization was approved.
Sessions on Day 2 of the Post Election Symposium included a fireside chat with futurist Ian Morrison and leaders from the ground discussed the long-term vision for rebuilding the health system.
Sessions on Day 1 of the Post Election Symposium provided an analysis of the election results and potential impacts for health care and a discussion on the gaps in our health care system that COVID-19 exposed.
November 16-17 | This virtual symposium will gather a range of experts after election day to discuss how the results could influence the health policy agenda in 2021 and beyond.
This briefing will overview the complex ecosystem of federal, state, and private programs that coexist to integrate medical, LTSS, and social services for low-income seniors.
Day 3 of our Voice of the Patient Summit, a program of the 2020 Signature Series, will address how we collect and operationalize patient feedback to create patient-centered care at a systems level.
Day 2 of our Voice of the Patient Summit, a program of the 2020 Signature Series, will explore successful mechanisms to support patients navigate the current, highly complex health care system and foster independence in decision making.
Day 1 of our Voice of the Patient Summit, a program of the 2020 Signature Series, includes an opening keynote presentation and panel focusing on strategies for effective communication and shared decision making from the patient and caregiver perspectives.
The COVID-19 pandemic has exposed both new and longstanding needs of long-term care patients. Experts will overview the recent changes, remaining gaps, and benefits and risks to long-term care patients, caregivers, providers, and payers.
This is the final event in Part I of our Signature Series focusing on disruptors and transformers in health care. This briefing explored the manufacturing, distribution, delivery, and coverage approaches that will enable nationwide COVID-19 vaccine uptake.
Dr. Anand Shah provided opening remarks and answered questions about the U.S. Food and Drug Administration’s role in the national COVID-19 response.
This solutions-focused discussion explored policy interventions at the federal, state, and local levels to advance mental health during the ongoing pandemic.
During this on-the-record briefing for reporters, Dr. Anthony S. Fauci, Director, National Institute of Allergy and Infectious Disease at the National Institutes of Health provided insight into the status of the COVID-19 pandemic. Dr. Fauci discussed the status of spread of the virus in the United States and highlighted progress toward successful treatments and vaccines.
This webinar will address the specific threats posed by COVID-19 to children in the short- and long-term and provide policy options that may support children’s physical and mental health.
During this webinar, panelists will address key questions such as: How has the relief fund been distributed to date among different health care entities? What is the financial impact of the pandemic for providers and what are the implications for access to health services? And, what factors should policymakers consider as they weigh additional options to support providers?
Keynote #2 of our Virtual Summit, a program of the 2020 Signature Series, will discuss the role of the National Institutes of Health’s National COVID Cohort Collaborative (N3C) program in fostering robust-data driven clinical research.
Panel #3 of our Virtual Summit, a program of the 2020 Signature Series, will explore the role of data sharing, interoperability, and health IT in tracking and stemming the spread of COVID-19.
Panel #2 of our Virtual Summit, a program of the 2020 Signature Series, will focus on care delivery and payment transformations that have been accelerated or emerged as a result of COVID-19 and explore which systemic changes may become permanent, as well as how to rebuild trust in the health care system.
Keynote #1 of our Virtual Summit, a program of the 2020 Signature Series, will explore structural conditions that have lead to health disparities before COVID and during the current pandemic.
Panel #1 of our Virtual Summit, a program of the 2020 Signature Series, will explore interactions between the vaccine development pipeline, medical supply chain, and contact tracing infrastructures currently serving the US, and how policymakers can leverage and improve these foundational systems moving forward.
Just over 100 days have passed since the COVID-19 pandemic was declared a national emergency on March 13, 2020. The pandemic has led to sweeping ramifications throughout the American economy and society as a whole. During this interactive discussion, three preeminent health policy leaders will examine the lessons learned three months into the crisis and lay out considerations for decision-makers as they work to stem the tide of the pandemic and build a more resilient health care system.
During this webinar, panelists addressed the following learning goals: the short- and long-term impact of COVID-19 on mental health and well being; evidence-based interventions and promising technology to reach people where they are and improve outcomes; and sustainable solutions to address the mental health impact of COVID-19 and advance access to behavioral health services beyond the pandemic.
During this webinar, speakers examined the following learning goals: the disproportionate impact of COVID-19 on Black, Indigenous, and People of Color communities in the U.S.; the drivers of these disparities; and short- and long-term policy options to advance equity and improve COVID-19 outcomes.
This webinar will explain the role of Medicaid in the COVID-19 pandemic. Panelists will discuss financing challenges of the Medicaid program—the nation’s health care safety net—as more people become eligible for Medicaid coverage and demand for health services shifts.
During this webinar, panelists discussed the recent evolution of our primary care system and outlined policy levers to bolster our nation’s primary care infrastructure.
During this webinar, panelists explored the impact of the pandemic on different facets of the drug supply chain and discussed policy options to strengthen the system.
During this webinar, panelists discussed case studies from abroad and best practices as policymakers look to implement a contact tracing strategy in the United States.
During this webinar, panelists discussed policy options to support high quality care for nursing home residents during the COVID-19 pandemic.
During this webinar, panelists will explore options policymakers can pursue to strengthen our surveillance infrastructure as we move from mitigation to containment of the COVID-19 pandemic.
In this webinar, panelists will discuss the unique challenges that face rural health systems and the strategies they are employing during the emergency response. They will also highlight current or future legislative and administrative policy solutions.
During this webinar, experts discussed steps necessary to bring vaccines from the lab to the front lines.
During this webinar, panelists discussed the consequences of social isolation, as well as potential interventions that government leaders, providers, and communities can implement.
During this pre-recorded interview, we spoke with Dr. Richard A. Stone, the VHA’s Executive in Charge. He explained the coronavirus response efforts underway at the Department of Veterans Affairs to meet the needs of veterans and fulfill the department’s “Fourth Mission” to support other health systems responding to this crisis.
With mandated lockdowns and social distancing guidelines in effect throughout the country, policymakers and public health professionals aim to identify other effective approaches to contain the spread of COVID-19. During this teleconference, experts will discuss the prescription drug supply chain, the progression of a COVID-19 vaccine, and the related infrastructure needs.
During this webinar, Dr. Mark McClellan, former FDA Commissioner and current director of the Duke-Margolis Center for Health Policy, offered strategies to expedite the development and evaluation of medical products to track, treat, and prevent the novel coronavirus.
As the coronavirus spreads, health systems across the country are gearing up for an influx of patients. States play a central role in the organization of health care and public health infrastructure, but a range of resources and legislative decisions, as well as different demographics, can lead to divergent outcomes across states.
The rapid spread of the novel coronavirus has led to a growing number of COVID-19 hospitalizations and concerns about health system capacity. Models and projections can be useful tools to help policymakers at the state and local levels make evidence-based decisions to slow the spread of the virus and bolster health system capacity. During this webinar, panelists highlighted the role of modeling in helping states prepare and respond to COVID-19.
During this pre-recorded interview, we spoke with Dr. Rebecca Katz, who explored how decision-makers can use these tools to weigh policy tradeoffs. She discussed the range of existing models, as well as the key inputs and assumptions that drive projections.